Literature DB >> 26207210

(18)F-FDG-PET/CT in the assessment of pulmonary solitary nodules: comparison of different analysis methods and risk variables in the prediction of malignancy.

Ober van Gómez López1, Ana María García Vicente1, Antonio Francisco Honguero Martínez1, Germán Andrés Jiménez Londoño1, Carlos Hugo Vega Caicedo1, Pablo León Atance1, Ángel María Soriano Castrejón1.   

Abstract

OBJECTIVE: To compare the diagnostic performance of different metabolical, morphological and clinical criteria for correct presurgical classification of the solitary pulmonary nodule (SPN).
METHODS: Fifty-five patients, with SPN were retrospectively analyzed. All patients underwent preoperative (18)F-fluorodeoxyglucose (FDG)-positron emission tomography (PET)/computed tomography (CT). Maximum diameter in CT, maximum standard uptake value (SUVmax), histopathologic result, age, smoking history and gender were obtained. Different criteria were established to classify a SPN as malignant: (I) visually detectable metabolism, (II) SUVmax >2.5 regardless of SPN diameter, (III) SUVmax threshold depending of SPN diameter, and (IV) ratio SUVmax/diameter greater than 1. For each criterion, statistical diagnostic parameters were obtained. Receiver operating characteristic (ROC) analysis was performed to select the best diagnostic SUVmax and SUVmax/diameter cutoff. Additionally, a predictive model of malignancy of the SPN was derived by multivariate logistic regression.
RESULTS: Fifteen SPN (27.3%) were benign and 40 (72.7%) malignant. The mean values ± standard deviation (SD) of SPN diameter and SUVmax were 1.93±0.57 cm and 3.93±2.67 respectively. Sensitivity (Se) and specificity (Sp) of the different diagnostic criteria were (I): 97.5% and 13.1%; (II) 67.5% and 53.3%; (III) 70% and 53.3%; and (IV) 85% and 33.3%, respectively. The SUVmax cut-off value with the best diagnostic performance was 1.95 (Se: 80%; Sp: 53.3%). The predictive model had a Se of 87.5% and Sp of 46.7%. The SUVmax was independent variables to predict malignancy.
CONCLUSIONS: The assessment by semiquantitative methods did not improve the Se of visual analysis. The limited Sp was independent on the method used. However, the predictive model combining SUVmax and age was the best diagnostic approach.

Entities:  

Keywords:  Positron emission tomography (PET); clinical variables; diagnostic accuracy; metabolic criteria; solitary pulmonary nodule (SPN)

Year:  2015        PMID: 26207210      PMCID: PMC4483468          DOI: 10.3978/j.issn.2218-6751.2015.05.07

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN: 2218-6751


  27 in total

1.  Fleischner Society: glossary of terms for thoracic imaging.

Authors:  David M Hansell; Alexander A Bankier; Heber MacMahon; Theresa C McLoud; Nestor L Müller; Jacques Remy
Journal:  Radiology       Date:  2008-01-14       Impact factor: 11.105

Review 2.  Standards for PET image acquisition and quantitative data analysis.

Authors:  Ronald Boellaard
Journal:  J Nucl Med       Date:  2009-04-20       Impact factor: 10.057

3.  [(18)F-FDG PET-CT and respiratory synchronization: effect in the detection and catalogation of pulmonary lesions].

Authors:  A M García Vicente; A Soriano Castrejón; P Talavera Rubio; V M Poblete García; A Palomar Muñoz; I Cepedello Boiso; B González García; J M Cordero García; M Bellón Guardia; J P Pilkington Woll
Journal:  Rev Esp Med Nucl       Date:  2009-07-07

Review 4.  Imaging of solitary pulmonary nodule-a clinical review.

Authors:  Yee Ting Sim; Fat Wui Poon
Journal:  Quant Imaging Med Surg       Date:  2013-12

5.  Risk stratification of solitary pulmonary nodules by means of PET using (18)F-fluorodeoxyglucose and SUV quantification.

Authors:  Aleksandar Grgic; Yildirim Yüksel; Andreas Gröschel; Hans-Joachim Schäfers; Gerhard W Sybrecht; Carl-Martin Kirsch; Dirk Hellwig
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-02-06       Impact factor: 9.236

6.  Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA.

Authors:  M T van Rens; A B de la Rivière; H R Elbers; J M van Den Bosch
Journal:  Chest       Date:  2000-02       Impact factor: 9.410

7.  Risks of Transthoracic Needle Biopsy: How High?

Authors:  Renda Soylemez Wiener; Daniel C Wiener; Michael K Gould
Journal:  Clin Pulm Med       Date:  2013-01-01

8.  Fluoro-deoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: assigning a probability of malignancy may be preferable to binary readings.

Authors:  Suk Chul Kim; Suk C Kim; Josef Machac; Borys R Krynyckyi; Karin Knesaurek; Daniel Krellenstein; Barbara Schultz; Allen Gribetz; Louis DePalo; Alvin Teirstein; Chun K Kim
Journal:  Ann Nucl Med       Date:  2008-05-23       Impact factor: 2.668

9.  Incremental value of integrated FDG-PET/CT in evaluating indeterminate solitary pulmonary nodule for malignancy.

Authors:  Chih-Yung Chang; Ching Tzao; Shih-Chun Lee; Cheng-Yi Cheng; Chang-Hsien Liu; Wen-Sheng Huang; Chih-Hung Ku; Jong-Kang Lee; Ching-Yee Oliver Wong
Journal:  Mol Imaging Biol       Date:  2009-06-20       Impact factor: 3.488

10.  Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.

Authors:  Ur Metser; Einat Even-Sapir
Journal:  Semin Nucl Med       Date:  2007-05       Impact factor: 4.446

View more
  16 in total

1.  Comments on characterization of solitary pulmonary nodules with 18F-FDG PET/CT relative activity distribution analysis.

Authors:  Orazio Schillaci; Ferdinando F Calabria
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

2.  Performance of FDG-PET/CT in solitary pulmonary nodule based on pre-test likelihood of malignancy: results from the ITALIAN retrospective multicenter trial.

Authors:  Laura Evangelista; Alberto Cuocolo; Leonardo Pace; Luigi Mansi; Silvana Del Vecchio; Paolo Miletto; Silvia Sanfilippo; Sara Pellegrino; Luca Guerra; Giovanna Pepe; Giuseppina Peluso; Marco Salvatore; Rosj Galicchio; Michele Zuffante; Salvatore Annunziata; Mohsen Farsad; Agostino Chiaravalloti; Marco Spadafora
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-05-07       Impact factor: 9.236

3.  Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions.

Authors:  Margarita Kirienko; Luca Cozzi; Alexia Rossi; Emanuele Voulaz; Lidija Antunovic; Antonella Fogliata; Arturo Chiti; Martina Sollini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04-06       Impact factor: 9.236

4.  [Combined use of thin-section CT and 18F-FDG PET/CT for characterization of solitary pulmonary nodules].

Authors:  Yun-Yan Ren; You-Cai Li; Hu-Bing Wu; Quan-Shi Wang; Yan-Jiang Han; Wen-Lan Zhou; Hong-Sheng Li; Zhen Wang; Mohammed Shah Alam Mohammed Shah Alam
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-03-20

5.  Contribution of nonattenuation-corrected images on FDG-PET/CT in the assessment of solitary pulmonary nodules.

Authors:  Ertan Şahin; Ahmet Kara; Umut Elboğa
Journal:  Radiol Med       Date:  2016-08-27       Impact factor: 3.469

6.  Comparing the diagnostic value of 18F-FDG-PET/CT versus CT for differentiating benign and malignant solitary pulmonary nodules: a meta-analysis.

Authors:  Yuzhu Jia; Wanfeng Gong; Zhiping Zhang; Gaofeng Tu; Jiapeng Li; Fanfan Xiong; Hongtao Hou; Yunyi Zhang; Meiqian Wu; Liping Zhang
Journal:  J Thorac Dis       Date:  2019-05       Impact factor: 2.895

7.  18F-fluorodeoxyglucose positron emission tomography/computed tomography in the diagnosis of benign pulmonary lesions in sarcoidosis.

Authors:  Ming Zhao; Xiao-Feng Xin; Huan Hu; Xian-Hui Pan; Tang-Feng Lv; Hong-Bing Liu; Jian-Ya Zhang; Yong Song
Journal:  Transl Lung Cancer Res       Date:  2019-06

8.  Diagnostic performance of fluorine-18 fluorodeoxyglucose positron emission tomography in the management of solitary pulmonary nodule: a meta-analysis.

Authors:  Duilio Divisi; Mirko Barone; Luca Bertolaccini; Gino Zaccagna; Francesca Gabriele; Roberto Crisci
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

9.  Characterization of 18F-fluorodeoxyglucose metabolic spatial distribution improves the differential diagnosis of indeterminate pulmonary nodules and masses with high fluorodeoxyglucose uptake.

Authors:  Jie Lin; Ling Wang; Xiaowei Ji; Xiangwu Zheng; Kun Tang
Journal:  Quant Imaging Med Surg       Date:  2021-04

10.  Quantitative volumetric metabolic measurement of solitary pulmonary nodules by F-18 fluorodeoxyglucose positron emission tomography-computed tomography.

Authors:  Tarık Şengöz; Dogangün Yüksel; Olga Yaylalı; Haydar Arslan; Ferda Bir
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2019-10-23       Impact factor: 0.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.